14 results  1 of 1 

1 Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho
Endocrinol Metab.2023;38(1):1-9.   Published online 2023 February 13     DOI: http://dx.doi.org/10.3803/EnM.2023.103
      
2 Appetite Control Mechanisms and Obesity
Eun Roh
J Korean Diabetes.2022;23(2):89-96.   Published online 2022 June 30     DOI: http://dx.doi.org/10.4093/jkd.2022.23.2.89
      
3 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
Soyeon Yoo, Eun-Jin Yang, Gwanpyo Koh
Diabetes Metab J.2019;43(4):495-503.   Published online 2019 February 20     DOI: http://dx.doi.org/10.4093/dmj.2018.0105
      
4 Effect of Nutrient Preload and Food Order on Glucose, Insulin, and Gut Hormones
Jae Hyun Bae, Young Min Cho
J Korean Diabetes.2018;19(4):193-199.   Published online 2018 December 28     DOI: http://dx.doi.org/10.4093/jkd.2018.19.4.193
      
5 An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
Suk Chon, Jean-François Gautier
Diabetes Metab J.2016;40(2):99-114.   Published online 2016 April 25     DOI: http://dx.doi.org/10.4093/dmj.2016.40.2.99
      
6 Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
Min Jung Jung, Su Kyoung Kwon
Endocrinol Metab.2014;29(4):536-544.   Published online 2014 December 29     DOI: http://dx.doi.org/10.3803/EnM.2014.29.4.536
      
7 Simulation of Oral Glucose Tolerance Tests and the Corresponding Isoglycemic Intravenous Glucose Infusion Studies for Calculation of the Incretin Effect
Myeungseon Kim, Tae Jung Oh, Jung Chan Lee, Karam Choi, Min Young Kim, Hee Chan Kim, Young Min Cho, Sungwan Kim
J Korean Med Sci.2014;29(3):378-385.   Published online 2014 February 27     DOI: http://dx.doi.org/10.3346/jkms.2014.29.3.378
      
8 Pleiotropic Effects of an Incretin Hormone
Seungjoon Oh
J Korean Diabetes.2013;14(3):120-124.   Published online 2013 January 10     DOI: http://dx.doi.org/10.4093/jkd.2013.14.3.120
   
9 Clinical Efficacy of Glucagon Like Peptide-1 (GLP-1) Analogues
Hyun-Ji Chun, Hyuk-Sang Kwon
J Korean Diabetes.2013;14(3):125-127.   Published online 2013 January 10     DOI: http://dx.doi.org/10.4093/jkd.2013.14.3.125
   
10 Understanding the Cardiovascular Effects of Incretin
Ji Sung Yoon, Hyoung Woo Lee
Diabetes Metab J.2011;35(5):437-443.   Published online 2011 October 31     DOI: http://dx.doi.org/10.4093/dmj.2011.35.5.437
      
11 The Role of the Sweet Taste Receptor in Enteroendocrine Cells and Pancreatic β-Cells
Itaru Kojima, Yuko Nakagawa
Diabetes Metab J.2011;35(5):451-457.   Published online 2011 October 31     DOI: http://dx.doi.org/10.4093/dmj.2011.35.5.451
      
12 GLP-1 Can Protect Proinflammatory Cytokines Induced Beta Cell Apoptosis through the Ubiquitination
Dong Mee Lim, Ju Young Kim, Kang Woo Lee, Keun Young Park, Byung Joon Kim
Endocrinol Metab.2011;26(2):142-149.   Published online 2011 June 30     DOI: http://dx.doi.org/10.3803/EnM.2011.26.2.142
      
13 The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
Mi-Hyun Kim, Moon-Kyu Lee
Korean Diabetes J.2010;34(1):2-9.   Published online 2010 February 28     DOI: http://dx.doi.org/10.4093/kdj.2010.34.1.2
      
14 Incretin-based Combination Therapy in Type 2 Diabetes Mellitus
Jae Hyeon Kim, Myung-Shik Lee
J Korean Med Assoc.2009;52(10):1030-1036.   Published online 2009 October 31     DOI: http://dx.doi.org/10.5124/jkma.2009.52.10.1030
      

 1 of 1